A leading biotech analyst and an investment banker give their perspectives on the future of biotech.
The biotech industry has made huge strides over the past ten years. Today's industry, which features over 180 approved products, revenues of approximately $50 billion and a market value well over $300 billion, is barely recognizable as the same industry that in 1996 featured just 34 approved products, revenues of $9 billion and a market value of $52 billion. But is the future as rosy?
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, E., Strupp, D. Crystal gazing: biotech's financial outlook. Nat Biotechnol 24, 261 (2006). https://doi.org/10.1038/nbt0306-261a
Issue Date:
DOI: https://doi.org/10.1038/nbt0306-261a